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	 This	 review	 deals	 with	 synthesis,	 reactions	 and	 their	 applications	 of	 pyranotriazolo‐
pyrimidines.	 The	 main	 purpose	 of	 this	 review	 is	 present	 a	 survey	 of	 literatures	 on	 the
reactivity	of	amino	imino	derivatives	and	carboxylic	acid	derivatives.	Some	of	these	reactions
have	been	applied	successfully	to	the	synthesis	of	biological	important	compounds.	
Naphthols	
Pyrimidine	
Biological	activity	
Pyranopyrimidines	
α‐Cyanocinnamonitriles	
Carboxylic	acid	derivatives	
	
1.	Introduction	
	
Pyran	 derivatives	 have	 attracted	 a	 great	 deal	 of	 interest	
owing	 to	 their	 antimicrobial	 activity	 [1‐7],	 inhibition	 of	 influ‐
enza,	 virus	 sialidase	 [8],	 mutagenic	 activity	 [9],	 activity	 as	
antiviral	 [10],	 anti‐proliferaction	agents	 [11],	 sex	pheromones	
[12],	antitumor	[13]	and	anti‐inflammatory	agents	[14].	
The	condensation	of	a	ring	of	1,2,4‐triazole	and	another	one	
of	 pyrimidine	 gives	 rise to	 the	 formation	 of	 bicyclic	 hetero‐
cycles	 known	 as	 1,2,4‐triazolopyrimidines.	 Four different	
possibilities	 exist	 for	 the	 relative	 orientation	of	both	 rings,	 so	
four	 different isomeric	 families	 of	 compounds	 are	 defined:	
1,2,4‐triazolo[1,5‐a]pyrimidine	 (I), 1,2,4‐triazolo[1,5‐c]pyrimi‐
dine	 (II),	 1,2,4‐triazolo[4,3‐a]pyrimidine	 (III)	 and	 1,2,4‐	
triazolo[4,3‐c]pyrimidine	(V)	(Figure	1).	
Among	 these	 isomeric	 families	 of	 compounds,	 1,2,4‐
triazolo[1,5‐a]‐pyrimidine derivatives	 are	 thermodynamically	
more	 stable	 and,	 thus,	 the	 most	 studied	 ones	 [15],	 a few	 of	
them	 being	 commercially	 available.	 Revisions	 surveying	 the	
synthesis,	 reactivity,	 spectroscopic	 characterization	 and	
crystallographic	 studies	 of	 1,2,4‐triazolo[1,5‐c]‐pyrimidines	
[16],	 1,2,4‐triazolo[4,3‐a]pyrimidines	 [17]	 and	 1,2,4‐triazolo	
[4,3‐c]pyrimidines	[18]	have	also	been	published.	
From	 the	 standpoint	 of	 biological	 activity,	 fused	 hetero‐
aromatic	 systems	 are often	 of	much	 greater	 interest	 than	 the	
constituent	 monocyclic	 compounds.	 Recently,	 1,2,4-triazolo	
[1,5‐a]pyrimidines	have	aroused	increasing	attention	from	the	
chemical and	 biological	 view	 points,	 due	 to	 their	 diverse	
pharmacological	 activities,	 such	as antitumor	potency	 [19,20],	
inhibition	 of	 KDR	 kinase	 [21],	 antifungal	 effect	 [22]	 and 
macrophage	activation	[23].	
	
	
	
Figure	1.	Structures	of	triazolopyrimidines.	
	
They	have	proved	to	be	promising	anticancer	agents	with 
dual	mechanisms	of	tubulin	polymerization	promotion	[19,20]	
as	 well	 as	 anti‐mycobacterial	 agents	 [24].	 Some	 examples	 of	
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published	 derivatives	 of	 1,2,4-triazolo[1,5‐a]pyrimidine	 with	
their	biological	activities	are	as	following.	
	
2.	Synthesis	of	pyrano	triazolo	pyrimidine	derivatives	 
	
2.1.	Synthesis	from	6‐methoxy‐2‐naphthol	[25‐27]	
	
Condensation	 of	 6‐methoxy‐2‐naphthol	 (1)	 with	 α‐
cyanocinnamonitriles	 (2a‐f)	 afforded	 the	 corresponding	 2‐
amino‐4‐(aryl)‐7‐methoxy‐4H‐naphtho[2,	 1‐b]pyran‐3‐carbo	
nitriles,	3a‐c,	ethoxymethylene	derivatives	(4a‐c)	was	obtained	
by	 refluxing	 compounds	 2‐amino‐4‐(aryl)‐7‐methoxy‐4H‐
naphtho[2,1‐b]pyran‐3‐carbonitriles	(3a‐c)	with	triethyl	ortho‐
formate	 as	 electrophile	 in	 the	 presence	 of	 acetic	 anhydride.	
Hydrazinolysis	of	ethoxymethylene	derivatives	4a‐c	in	ethanol,	
at	 room	 temperature	 furnished	 the	 novel	 10‐amino‐10,11‐
dihydro‐11‐imino‐3‐methoxy‐12‐(aryl)‐12H‐naphtho	 [2,	 1‐b]	
pyrano[2,3‐d]pyrimidine	 derivatives	 5a‐c	 in	 good	 yield.	
Reaction	 of	 aminoimino	 derivatives	 5a‐c	 with	 formic	 acid	 or	
triethyl	 ortho‐formate	 affords	 the	 corresponding	 pyrano	
triazolo‐pyrimidine	 derivative	 6a.	 Also	 compounds	 5a‐c	
reacted	 with	 acetylchloride	 and	 or	 benzoyl	 chloride	 gave	 the	
corresponding	 11‐methoxy‐2‐methyl/phenyl‐14‐(aryl)‐14H‐
naphtho[2,1‐b]‐pyrano[2,3‐e][1,2,4]triazolo[1,5‐c]pyrimidines	
(6b,c),	while	cyclo‐condensation	of	compound	5a‐c	with	ethyl	
cyanoacetate	or	 diethyl	 oxalate	afforded	 the	 corresponding	2‐
cyanomethyl	 and	 2‐ethoxycarbonyl	 derivatives	 6d	 and	 6e,	
respectively	(Scheme	1).		
	
 
	
Scheme	1	
	
Treatment	 of	 10‐amino‐10,11‐dihydro‐11‐imino‐3‐met‐	
hoxy‐12‐(p‐tolyl)‐12H‐naphtho[2,1‐b]pyrano[2,3‐d]pyrimidine	
(5a)	 with	 two	 moles	 of	 ethylchloroformate	 in	 dry	 benzene	
afforded	1:2	adduct	7.	Formation	of	compound	7	was	assumed	
to	 proceed	 via	 bis(ethoxylcarbonyl)	 derivative	 [A]	 as	
intermediate,	which	cyclized	into	compound	7	with	elimination	
of	ethanol	(Scheme	2).		
	
	
Scheme	2	
	
While	 treatment	 of	 10‐amino‐10,11‐dihydro‐11‐imino‐3‐
methoxy‐12‐(p‐chloro/bromophenyl)‐12H‐naphtho	 [2,	 1‐b]	
pyrano‐[2,3‐d]	 pyrimidine	 (5b,c)	 with	 ethylchloroformate	 in	
dry	 benzene	 afforded	 11‐methoxy‐14‐(p‐chloro/bromo	
phenyl)‐2‐oxo‐2H,3H,14H‐naphtho[2,1‐b]‐pyrano[3,2‐e][1,2,4]	
triazolo[1,5‐c]pyrimidines	 (8a,b).	 Reaction	 of	 compound	5b,c	
with	CS2/alc.	KOH	gave	 triazolo‐2‐thiones	 (8c,d),	 respectively,	
(Scheme	3).	
	
	
Scheme	3	
	
2.2.	Synthesis	from	6‐bromo‐2‐naphthol	[28,29]	
	
Condensation	 of	 various	 substituted	 α‐cyanocinnamo	
nitriles	 2a,c	 with	 6‐bromo‐2‐naphthol	 (10)	 in	 ethanolic	
piperidine	 afforded	 the	 corresponding	 2‐amino‐4‐(aryl)‐7‐
bromo‐4H‐naphtho[2,1‐b]pyran‐3‐carbonitriles	(11a‐e).	Treat‐
ment	of	compounds	11a‐d	with	triethyl	ortho‐formate	in	acetic	
anhydride	 at	 reflux	 gave	 the	 corresponding	 ethoxylmethylen	
amino	derivatives	12a‐d.	Hydrazinolysis	of	compounds	12a‐d	
in	ethanol	at	room	temperature	afforded	the	imino	derivatives	
13a‐d.	 Interaction	 of	 compounds	 13a,b	 with	 triethyl	 ortho‐
formate	 afforded	 11‐bromo‐14‐(p‐tolyl	 or	 p‐methoxyphenyl)‐
14H‐naphtho[1`,2`:5,6]pyrano[3,2‐e][1,2,4]triazolo[2,3‐c]pyri‐
midines	(14a,b),	respectively,	(Scheme	4).	
Reaction	 of	 compounds	 13a,b	 with	 acetyl	 chloride	 and	
ethyl	cyano	acetate	at	reflux	the	corresponding	2‐methyl‐14‐(p‐
tolyl	 or	 p‐methoxyphenyl)‐14H‐naphtho‐[2,1‐b]pyrano[2,3‐
e][1,2,4]triazolo[1,5‐c]pyrimidines	 (14c,d)	 and	 2‐acetonitrile‐
14‐	 (p‐tolyl	 or	p‐methoxyphenyl)‐14H‐naphtho[2,1‐b]	 pyrano‐
[2,3‐e][1,2,4]triazolo[1,5‐c]pyrimidines	 (14e,f),	 respectively,	
were	 formed.	 Reaction	 of	 compounds	 13a,b	 with	 diethyl	
oxalate	and	benzoyl	chloride	at	reflux	afforded	the	correspond‐
ding	 2‐ethoxycarbonyl	 14g,h	 and	 2‐phenyl	 14i,j	 derivatives.	
Reaction	of	compound	13a	with	methyl	or	ethyl	chloroformate	
(1	mole)	 in	dry	benzene	afforded	 the	1:1	adduct	 triazol‐2‐one	
15,	 Instead	 of	 the	 anticipated	 formation	 of	 the	 triazolo	
pyrimidine	 derivative	15	 the	 reaction	 of	 compound	13d	with	
methyl	 or	 ethyl	 chloroformate	 in	 dry	 benzene	 afforded	 16,	
through	nucleophilic	displacement	followed	by	spontaneous		
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Scheme	4
	
	
hydrolysis	of	the	ester	intermediate	[B]	into	the	corresponding	
carbamic	 acid	 derivative	 16.	 Interaction	 of	 compound	 13a,d	
with	 benzaldehydes	 in	 dioxane/piperidine	 afforded	 14j	 and	
dihydrotriazolopyrimidine	derivative	17	and	non‐isolable	14i,	
respectively,	(Scheme	5).	
	
 
	
Scheme	5	
	
2.3.	Synthesis	from	2‐naphthol	[30]		
	
Condensation	 of	 α‐cyanocinnamonitrile	 2a,	 with	 2‐
naphthol	 in	 ethanolic	 piperidine	 afforded	 2‐amino‐4‐(p‐tolyl)‐
4H‐naphtho[2,1‐b]‐pyran‐3‐carbonitrile	 (18).	 Treatment	 of	
compound	18	with	 triethyl	ortho‐formate	 in	 acetic	 anhydride	
at	 reflux	 gave	 the	 corresponding	 ethoxylmethylenamino	
derivative	 19.	 Hydrazinolysis	 of	 compound	 19	 in	 ethanol	 at	
room	 temperature	 afforded	 the	 imino	 derivative	 20.	
Interaction	of	compound	20	with	triethyl	ortho‐formate,	acetyl	
chloride,	 benzoyl	 chloride,	 ethyl	 cyanoacetate,	 diethyl	 oxalate	
afforded	 the	 corresponding	 triazolopyrimidine	 derivatives	
21a‐e	(Scheme	6).	
	
 
	
Scheme	6	
	
2.4.	Synthesis	from	naphtho[2,1‐b]pyrans	[31]	
	
Reaction	 of	 2‐amino	 4‐aryl‐3‐cyano‐4H‐naphtho[2,1‐
b]pyrans	18	and	22	with	triethyl	ortho‐formate,	triethyl	ortho‐
acetate	or	triethyl	ortho‐propionate	in	1,4‐dioxane,	in	presence	
amount	 of	 acetic	 acid	 under	 reflux	 to	 give	 2‐[(ethoxy	
alkylidene)amino‐4‐aryl‐3‐cyano‐4H‐naphtho‐[2,1‐b]pyrans	19	
and	23,	respectively,	(Scheme	7).	
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Scheme	7	
	
The	 reaction	 of	 these	 imidates	 19	 and	 23,	 with	 tosyl	
hydrazine,	 in	 toluene	 at	 reflux	 and	 few	 drops	 of	 acetic	 acid,	
afforded	 the	 desired	 key	 intermediate	N1‐tosylamino‐11‐aryl‐
1,12‐dihydro‐11H‐naphthopyrano‐[2,	 3‐d]pyrimidine	 (24)	
(Scheme	8).	
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Scheme	8	
	
In	 the	 next	 step,	 condensed	 the	 N1‐tosylaminonaphtha	
pyrano[2,3‐d]pyrimidines	24,	with	an	excess	of	 triethyl	ortho‐
formate	 to	 give	 14‐aryl‐14H‐naphtho[2,1‐b]pyrano[3,2‐
e][1,2,4]triazolo[1,5‐c]yrimidines	 (25a‐m).	 The	 formation	 of	
compounds	21a	and	25a‐m	can	be	explained	by	asequence	of	
events	via	 intermediates	of	 type	 [C],	 formed	 in	the	reaction	of	
N1‐tosylaminonaphthopyrano[2,3‐d]pyrimidines	 24	 with	
triethyl	ortho‐formate,	followed	by	spontaneous	ethyl	4‐methyl	
benzenesulfonate	elimination	(Scheme	9).	
	
2.5.	Synthesis	from	imino	ethers	[32]	
	
Imino	 ethers	 are	 known	 to	 react	 with	 compounds	
containing	 ‐NH2	 moiety	 such	 as	 hydrazides	 [33‐35].	 In	 fact	
imino	ethers	(26)	possess	two	reactive	sites,	a	cyano	group	and	
an	 imidic	 carbon.	 These	 groups	 render	 them	 susceptible	 to	
react	with	hydrazides	under	 toluene	 reflux	 in	 the	presence	of	
few	drops	of	acetic	acid	 to	give	new	compounds.	As	shown	 in	
(Scheme	 10)	 two	 plausible	 pathways	 and	 different	 products	
could	be	expected.	
i)	Successive	two	nucleophilic	additions	of	(‐NH2	group)	on	
the	 imidic	 carbon	 and	 on	 the	 cyano	 function	 to	 yield	 amido	
pyranopyrimidines	 [D].	 In	 this	 case	 hydrazides	 react	 with	
iminoethers	26	 like	 hydroxylamine,	 primary	 amines	 [36]	 and	
tosylhydrazine	 [37].	 The	 intermediate	 [D]	 can	 be	 intra‐
cyclisation	 via	 elimination	 of	 water	 to	 give	 pyrano	 triazolo‐
pyrimidine,	27.	
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Scheme	9	
	
ii)	 Successive	 two	 nucleophilic	 additions	 of	 two	 nitrogen	
atoms	of	NH2‐NH	moiety	on	the	reactive	sites	of	iminoethers	26	
to	yield	pyranotriazepines	28	or	their	isomers	29.		
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Scheme	10	
	
2.6.	Synthesis	from	4‐chloro‐1‐naphthol	[38]	
	
The	condensation	of	substituted	benzylidenmalonitile	(2a),	
with	 4‐chloro‐1‐naphthol	 (30)	 in	 the	 ethanolic	 piperidine	
afforded	 naphthopyran	31.	 Treatment	 of	 2‐amino‐6‐chloro‐4‐
(p‐tolyl	 )‐4H‐naphtho[1,2‐b]pyran‐3‐carbonitrile	 (31)	 with	
triethyl	 ortho‐formate	 in	 acetic	 acid	 at	 reflux	 gave	 the	
corresponding	 ethoxymethylideneamino	 derivative	 32.	
Compound	 32	 when	 react	 with	 hydrazine	 hydrate,	 the	
naphtho[2`:1`:5,6]pyrano[2,3‐d]pyrimidine	 derivative	 33	 was	
obtained,	 (Scheme	 11).	 Interaction	 of	 compound	 33	 with	
triethyl	 orthoformate	 or	 formic	 acid	 afforded	 the	 naphtha	
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[2`,1`:5,6]pyrano[3,2‐e][1,2,4]‐triazolo[1,5‐c]pyrimidine	 deri‐
vative	 34a,	 while	 with	 acetic	 acid	 or	 acetyl	 chloride	 the	
respective	2‐methyl	 derivative	34b	was	 obtained.	 Reaction	 of	
compound	 33	 with	 chloroacetyl	 chloride	 and	 trichloroaceto	
nitrile	at	reflux	yielding	the	corresponding	2‐chloromethyl	34c	
and	2‐trichloromethyl	34d	derivative,	respectively,	while	with	
ethyl	 cyanoacetate	 and	 benzoyl	 chloride	 afforded	 2‐cyano	
methyl	 34e	 and	 2‐phenyl	 34f	 derivative	 was	 obtained.	
Treatment	 of	 compound	33	with	diethyl	 oxalate	 in	 ethanol	 at	
reflux	 yielded	 the	 2‐ethoxycarbonyl	 derivative	 34g,	 respect‐
tively,	(Scheme	11).	
	
	
	
Scheme	11	
	
Treatment	 of	 compound	 33	 with	 ethyl	 chloroformate	 (1	
mole)	in	dry	benzene	afforded	a	1:1	adduct	35,	while	heating	of	
compound	33	with	ethyl	chloroformate	(2	moles)	under	reflux	
for	3	h	yielded	a	1:2	adduct,	36.		
The	 formation	of	compound	35	 is	assumed	to	proceed	via	
interaction	 of	 compound	 33	 with	 ethyl	 chloroformate	 with	
elimination	 of	 HCl	 to	 yield	 [E] ,which	 then	 cyclizes	 into	
compound	35	with	elimination	of	ethanol.	However,	compound	
36	 is	 assumed	 to	 be	 obtained	 via	 formation	 of	 a	 bis(ethoxy	
carbonyl)	derivative	[F],	which	cyclizes	into	compound	36	with	
elimination	of	ethanol	(Scheme	12).	
	
2.7.	Synthesis	from	4H‐chromene	derivatives	[39]	
	
Alkylation	 of	 2‐amino‐4‐(4‐chlorophenyl)‐7‐hydroxy‐4H‐
chromene‐3‐	 carbonitrile	 (37)	 using	 methyl	 or	 ethyl	 iodide	
afford	 2‐amino‐4‐(4‐chlorophenyl)‐7‐methoxy‐4H‐chromene‐
3‐carbonitrile	 (38a),	 and	 2‐amino‐4‐(4‐chlorophenyl)‐7‐
ethoxy‐4H‐chromene‐3‐carbonitrile	 (38b).	 Compounds	 38a	
and	 38b	 were	 reacted	 with	 triethyl	 orthoformate	 to	 give	
formimidate,	39a	 and	39b	 Interaction	 of	 compound	39a	 and	
39b	with	 equimolar	 amount	 of	hydrazine	hydrate	 in	 absolute	
ethanol	 at	 ambient	 temperature	 gave	 the	 key	 intermediates	
pyranopyrimidine	 derivatives	 40a,b	 Reaction	 of	 compound	
40a,b	 with	 triethyl	 orthoformate	 or	 ethyl	 ethoxymethylene	
cyanoacetate	afforded	pyranotriazolopyrimidines,	41a,b	While	
treatment	 of	 compounds	 40a,b	 with	 acetic	 anhydride	 or	
acetoacetone	 gave	 the	 corresponding	 pyranotriazolo	 pyrimi‐
dines	 42a,b	 and	 reaction	 of	 compounds	 40a,b	 with	 diethyl	
oxalate	 gave	 the	 corresponding	 pyrano	 triazolo	 pyrimidines	
43a,b.	 Treating	 compounds	40a,b	 with	 equimolar	 amount	 of	
chloro	acid	chloride	derivatives	in	dioxane	containing	catalytic	
amount	 of	 triethylamine	 afford	 triazolo	 derivatives	 45a‐d	
(Scheme	13).		
	
 
	
Scheme	12	
	
	
 
	
Scheme	13	
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Compounds	 triazolo‐pyrimidines	 46a‐f	 were	 prepared	
from	 the	 interaction	 of	 the	 key	 intermediates	 40a,b	 with	
different	 arylidene	 malononitriles	 2	 in	 the	 presence	 of	
piperidine	under	reflux	in	absolute	ethanol	(Scheme	14).	
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Scheme	14	
	
2.8.	Chromeno	pyrimidine	[40]	
	
The	 condensation	 between	 iminoether	 47	 and	 hydrazine	
hydrate	 in	 ethanol	 at	 room	 temperature	 afforded	 the	
pyimidines	 48	 in	 61%	 yield.	 The	 synthesis	 of	 triazol‐2‐one	
derivative	49	could	be	accomplished	through	the	interaction	of	
the	aminopyrimidine	48	and	ethyl	chloroformate,	in	anhydrous	
DMF	at	 reflux	 temperature	 for	1	h	 and	 resulted	 in	69%	yield.	
Treatment	 of	 compound	 48	 with	 carbon	 disulfide	 in	 an	
alcoholic	 solution	 of	 potassium	 hydroxide	 at	 reflux	 gave	 the	
triazol‐2‐thione,	50	(Scheme	15).	
		
 
	
Scheme	15	
	
The	 condensation	 between	 the	 aminopyrimidine	 48	 and	
different	 carboxylic	 acid	 such	as	 formic	 acid,	 acetic	 anhydride	
and	 trifluroacetic	 acid	 under	 reflux	 temperature	 readily,	 after	
aqueous	workup,	furnished	the	expected	triazole	products	51a‐
c.		
While	 compound	 48	 react	 with	 cyanogen	 bromide	 in	
absolute	 ethanol	 containing	 anhydrous	 potassium	 carbonate	
under	 reflux	 afforded	 2‐amino‐triazolo[1,5‐c]pyrimidin‐9‐ol,	
51d.	 Reaction	 between	 compound	 48	 and	 diethyl	 malonate	
was	conducted	 in	DMF	under	reflux	conditions;	elimination	of	
water	 and	 ethanol	 occurred	 and	 gave	 the	 acetate	 derivatives	
52,	 while	 condensation	 of	 compound	 48	 with	 methylcyano	
acetate	 in	 refluxing	 ethanol	 resulted	 in	 formation	 of	 the	
acetonitrile	derivative	53	(Scheme	16).	
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Scheme	16	
	
Interaction	 between	 the	 aminopyrimidine	 48	 and	
benzylidene‐malononitrile	2d	 in	a	basic	medium	was	expected	
to	 give	 compound	 54,	 but	 instead	 led	 interestingly	 to	
compound	55	which	 formed	when	 the	 reactants	 were	mixed	
together	 with	 few	 drops	 of	 acetone	 and	 left	 at	 room	
temperature	 for	 30	 min.	 The	 condensation	 between	
aminopyrimidine	 compound	 48	 and	 p‐nitrobenzaldehyde	 in	
ethanolic	 piperidine	 at	 reflux	 temperature,	 furnish	 the	
triazolopyrimidine	56	(Scheme	17).	
	
 
	
Scheme	17	
	
2.9.	Synthesis	from	4‐hydroxy	coumarin	[41‐44]	
	
This	 synthesis	 involves	 Michael	 cycloaddition	 reaction	 of	
the	 readily	 available	 4‐hydroxycoumarin	 (57)	 with	 α‐cyano	
crotononitrile	 (2a,b	and	e)	 in	ethanolic	piperidine	 to	afforded	
2‐amino‐3‐cyano‐4‐(p‐tolyl/p‐chlorophenyl	 or	 methyl)‐4H,5H‐
pyrano‐[3,2‐c][1]benzopyran‐5‐ones	 (58a‐c).	 Treatment	 of	 2‐
amino‐4‐(	 p‐tolyl/p‐chlorophenyl	 or	 methyl)‐3‐cyano‐4H,5H‐
pyrano[3,2‐c][1]benzopyran‐5‐ones	 (58a‐c)	 with	 triethyl	
ortho‐formate	 in	 acetic	 anhydride	 at	 reflux	 afforded	 4‐(p‐
tolyl/p‐chlorophenyl	 or	 methyl)‐3cyano‐2‐ethoxymethylene	
amino‐4H,5H‐pyrano[3,2‐c][1]benzo‐pyran‐5‐ones	 (59a‐c).	
Hydrazinolysis	 of	 the	 compound	 59	 in	 ethanol	 at	 room	
temperature	 yielded	 9‐amino‐7‐(	 p‐tolyl/p‐chlorophenyl	 or	
methyl)‐8	 ,9‐dihydro‐8‐imino‐6H,	 7H‐[1]benzopyrano[‐3`,	 4`:	
5,6]‐pyrano[2,3‐d]pyrimidine‐6‐ones	 (60a‐c)	 (Scheme	 18).	
Refluxing	compound	60a‐c	with	triethyl	orthoformate	afforded	
the	 [1,2,4]triazolo[1,5‐c]pyrimidines,	61a‐c,	 while	 with	 acetyl	
chloride	 or	 chloroacetyl	 chloride	 compounds	61d‐f	 and	61g‐i	
were	 formed,	 respectively.	 Reaction	 of	 compound	60a‐c	 with	
ethyl	 cyanoacetate	 and	 diethyl	 oxalate	 afforded	 the	 hetero	
cycles	 61j‐l	 and	 61m‐o,	 respectively,	 while	 with	 benzoyl	
chloride	the	2‐phenyl	derivatives	61p‐r	was	obtained	(Scheme	
18).		
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Scheme	18	
	
The	 reaction	 of	 compound	 60c	 with	 ethyl	 chloroformate,	
through	 nucleophilic	 displacement	 followed	 by	 spontaneous	
hydrolysis	 of	 the	 ester	 intermediate	 62,	 led	 to	 the	 corres‐
ponding	carbamic	acid	derivative	63,	instead	of	compound	64.	
While	 compound	60c	was	 reacted	with	 alcoholic	 CS2/alc.KOH	
to	 give	 14‐methyl‐2,3‐dihydro‐13‐oxo‐2H,13H,14H‐[1]benzo	
pyrano‐[3`,	4`:5,	6]‐pyrano[3,	2‐e][1,2,4]triazolo	[1,5‐c]‐pyrimi‐
dine‐2‐thione	(65),	respectively,	(Scheme	19).	
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Scheme	19	
	
When	 compound	 60b	 was	 treated	 with	 methyl	 chloro	
formate	 for	 30	 min,	 the	 methoxycarbonyl	 derivative	 66	 was	
formed,	 while	 heating	 of	 compound	 60b	 with	 methyl	
chloroformate	under	reflux	for	6	h	afforded	[1,2,4]triazolo[1,5‐
c]pyrimidine	67	 via	 elimination	 of	methanol	 from	 compound	
67	(Scheme	20).		
When	compound	60b	was	treated	with	ethyl	chloroformate	
(2	 moles)	 an	 intermediate	 bis(ethoxycarbonyl)	 derivative	 [G]	
was	formed,	which	eliminated	ethanol	to	 furnish	the	ester	68.	
Treatment	of	 compound	64	with	 carbon	disulfide	 in	 alcoholic	
potassium	hydroxide	solution	gave	 the	2‐thione	derivative	69	
(Scheme	21).	
	
 
	
Scheme	20	
	
	
 
	
Scheme	21	
	
2.10.	Synthesis	from	α‐tetralone	[45]	
	
Synthesis	 of	 2‐amino3‐cyano‐5,6‐dihydro‐spiro[benzo(h)	
chromene‐4(4H),3`(3H)indol]‐2`‐[1H]‐one	(73),	was	performed 
by	treating	of	a	mixture	of	α‐tetralone	(70)	with	1H‐indole‐2,3‐
dione	 (71)	 and	 malononitrile	 (72)	 as	 a	 ternary	 mixture.	
Heating	 under	 reflux	 73	 with	 triethyl	 orthoformate	 gave	 the	
corresponding	 ethyl	 methanimidate	 derivative	 74.	 Hydrazine	
hydrate	 with	 compound	 74	 gave	 the	 corresponding	 amino	
imino	 derivatives	 75.	 Refluxing	 of	 imino	 derivative	 75	 with	
formic	 or	 acetic	 acid	 gives	 the	 corresponding	 pyranotriazolo	
pyrimidine	derivatives	76a,b.	
Refluxing	 of	 compound	 75	 with	 ethyl	 cyanoacetate	 in	
dioxane	 affords	 the	 pyranotriazolopyrimidine	 derivative	 76c	
(Scheme	22).	
	
2.11.	Synthesis	form	3‐methyl‐pyranopyrazole	derivative	
[46]	
	
6‐Amino‐2,	 4‐dihydro‐3‐methyl‐4‐(p‐nitrophenyl)pyrano	
[2,3‐c]pyrazole‐5‐carbonitrile	 (77)	 [47,48],	 as	 the	 key	
compound	 for	 this	 study	 and	 for	 further	 syntheses	 of	 other	
fused	 heterocyclic	 compounds,	 was	 heated	 at	 reflux	
temperature	with	an	equimolar	amount	of	triethyl	orthoacetate	
in	 the	 presence	 of	 acetic	 anhydride	 to	 give	 a	 major	 product	
which	 could	 be	 assigned	 the	 structure	 of	 ethyl	N‐[2‐acetyl‐5‐
cyano‐3‐methyl‐4‐(p‐nitrophenyl)‐2,4‐dihydropyrano[2,3‐c]	
pyrazol‐6‐yl]ethanimidate	(78). 	
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When	 a	 solution	 of	 compound	 78,	 in	 dry	 benzene,	 was	
stirred	 with	 hydrazine	 hydrate,	 it	 afforded	 6‐amino‐3,7‐
dimethyl‐5‐imino‐4‐(p‐nitrophenyl)2,4,5,	6‐tetrahydropyrazolo	
[4`,3`:5,6]pyrano[2,3‐d]pyrimidine	 (79).	 When	 compound	 79	
was	refluxed	with	triethyl	orthoformate,	it	gave	5,10‐dimethyl‐
11‐(p‐nitrophenyl)‐9,11‐dihydropyrazolo	 [4`,3`:5,6]pyrano[3,	
2‐e][1,2,4]triazolo[1,5‐c]	 pyrimidine	 (80).	 Heating	 of	
compound	79	with	triethyl	orthoacetate	at	reflux	temperature,	
gave	 2,5,10‐trimethyl‐11‐(p‐nitrophenyl)‐9,11‐dihydro‐pyra	
zolo[4`,3`:5,6]‐pyrano[3,2e][1,2,4]triazolo‐[1,5‐c]	 pyrimidine	
(81),	respectively,	(Scheme	23).	
	
 
	
Scheme	22	
	
	
 
	
Scheme	23	
	
2.12.	Synthesis	from	1‐phenyl‐3‐methyl‐pyranopyrazole	
derivative	[49]	
	
Reaction	 of	 6‐amino‐4‐(4‐chlorophenyl)‐1,4‐dihydro‐3‐
methyl‐1‐phenyl‐pyrano[2,3‐c]pyrazole‐5‐carbonitrile	 (82)	
with	 triethyl	 ortho‐formate	 in	 acetic	 anhydride	 afforded	
methanimidate	derivative	(83),	hydrazinolysis	of	compound	83	
in	 methanol	 at	 room	 temperature	 afforded	 1‐phenyl‐4‐(p‐
chlorophenyl)pyrazolo[4`,3`:5,6]pyrano[2,3,‐d]pyrimidine	
(84).	 Compound	 84,	 considered	 as	 a	 key	 intermediate	 to	
prepare	fused	heterocycles	as	triazolo[1,5‐c]pyrimidines	which	
may	possess	pharmacological	properties.	
The	 cyclo‐condensation	 of	 compound	 84	 with	 the	
appropriate	 carboxylic	 acid	 derivatives	 was	 performed	 by	
heating	 with	 an	 excess	 of	 neat	 formic	 acid,	 triethyl	
orthoformate	or	ethoxymethylene	malononitrile	afforded	8,11‐
dihydro‐10‐methyl‐8‐phenyl‐11‐(p‐chlorophenyl)[4`,3`:5,6]	
pyrano‐[3,	 2‐e][1,	 2,	 4]triazolo[1,	 5‐c]pyrimidine	 (85).	When	
triethyl	orthoacetate	was	used	in	the	above	cyclocondensation	
3,10‐dimethyl‐8,11‐dihydro‐8‐phenyl‐11‐(p‐chlorophenyl)	
[4`,3`:5,6]‐pyrano[3,2‐e][1,2,4]triazolo[1,5‐c]pyrimidine	 (86)	
was	 produced.	 Compound	 86	 was	 also	 produced	 via	 the	
reaction	 of	 compound	84	with	 acetic	 anhydride	 as	 carboxylic	
acid	anhydride	and	acetyl	chloride	as	acid	chloride.	Moreover,	
the	 interaction	of	 triethyl	orthopropionate	with	compound	84	
afforded	 3‐ethyl‐8,11‐dihydro‐10‐methyl‐8‐phenyl‐11‐(p‐
chlorophenyl)‐[4`,3`:5,6]pyrano[3,2‐e][1,2,4]triazolo[1,	 5‐c]	
pyrimidine	(87),	respectively,	(Scheme	24).	
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Scheme	24	
	
In	 the	case	of	 involving	the	condensation	of	compound	84	
with	cyanogens	bromide	and	S‐methyl	 isothiourea	sulfate,	 the	
intermediate	formed	might	bear	a	cyanimino	[H]	or	guanidine	
function	[I].	These	intermediates	[H	and	I]	were	cyclized	in	an	
alkaline	 medium	 to	 give	 the	 target	 molecule	 88	 as	 expected	
(Scheme	25).	
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Scheme	25	
	
The	 formation	 of	 2‐trichloromethyl	 10‐methyl‐8,11‐
dihydro‐8‐phenyl‐11‐(p‐chlorophenyl)‐[4`,	 3`:5,	 6]pyrano[3,	2‐
e][1,2,4]triazolo[1,5‐c]‐	 pyrimidine	 (90)	 via	 the	 interaction	 of	
compound	 84	 with	 trichloroacetic	 acid	 in	 the	 presence	 of	
phosphoryl	 chloride	 under	 reflux,	 or	 trichloro‐acetonitrile	 in	
absence	 of	 solvent	 under	 reflux	 was	 unsuccessful.	 But	 The	
pyrimidinium	salt	89	only	isolable	product	(Scheme	26).	
	
 
	
Scheme	26	
	
The	 activity	 of	 compound	 84	 towards	 active	 methylene	
compounds,	 such	 as	 ethyl	 cyanoacetate	 was	 studied,	 to	 give	
9,12‐dihydro‐3‐hydroxyl‐11‐methyl‐8‐phenyl‐12‐(p‐chloro	
phenyl)‐2H‐pyrazolo[4`,3`:5,6]pyrano‐[2`,3`:5,6]pyrimido[1,6‐
b][1,2,4]triazine	 (91),	 but	 non‐isolable	 triazolopyrimidine	 92	
(Scheme	27).		
	
 
	
Scheme	27	
	
Compound	 84,	 when	 reacted	 with	 β‐cyanocinnamonitrile	
derivatives,	 namly	 p‐toylmalononitrile	 and	 p‐anisylmalono	
nitrile	respectively,	in	dioxane	under	reflux	and	in	the	presence	
of	 a	 catalytic	 amount	 of	 piperidine	 failed	 to	 afford	 pyrano	
triazolopyrimidine	 derivatives	 94	 and	 pyranopyrimidine	
derivatives	93a,b,	were	isolable	products,	via	the	formation	of	
1:1	adduct	followed	by	the	loss	of	malononitrile.	Also	the	same	
product	93a,b	was	 isolate	 from	 the	 reaction	of	 compound	84	
with	p‐tolulaldehyde	and	p‐anisaldehyde,	respectively,	(Scheme	
28).	
	
 
	
Scheme	28	
	
2.13.	Synthesis	from	spirooxindolopyran	[50]	
	
The	 reaction	 of	 spirooxindolopyran	 95	 with	 an	 excess	 of	
orthoformic	 ester	 leads	 to	 the	 ethoxymethyleneaminonitrile	
96,	 which	 enters	 into	 cascade	 heterocyclization	 with	 benzo	
hydrazide	 and	 subsequent	 closure	 of	 the	 pyrimidine	 and	
triazole	rings,	leading	to	a	high	yield	of	2'‐oxo‐2‐phenyl‐1',	2',	5,	
6,	 7,	 8‐hexahydrospiro[1‐benzopyrano[3,	 2‐e][1,	 2,	 4]triazolo	
[1,5‐c]pyrimidine‐2,3'‐[3H]indole]	 (97),	 respectively,	 (Scheme	
29).	
	
 
	
Scheme	29	
	
2.14.	Synthesis	from	8‐hydroxy‐2‐methylquinoline	[51,52]	
	
Condensation	of	8‐hydroxy‐2‐methylquinoline	(98)	with	p‐
chloro‐benzaldehyde	 in	 acetic	 anhydride	 under	 reflux	 or	
microwave	 irradiation	 afforded	 (E)‐2‐(4‐chlorostyryl)‐8‐
hydroxyquinoline	(99).		
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Scheme	30	
	
	
The	 reaction	 of	 (E)‐2‐(4‐chlorostyryl)‐8‐hydroxyquinoline	
(99)	 with	 α‐cyano‐p‐chloro‐cinnamonitrile	 (2b)	 in	 ethanolic	
piperidine	 under	 reflux	 afforded	 (E)‐2‐amino‐4‐(4‐
chlorophenyl)‐9‐(4‐chlorostyryl)‐4H‐pyrano[3,2‐h]‐quino	 line‐
3‐carbonitrile	(100).	Compound	100	was	subjected	for	further	
reactions	 to	 produce	 fused	 heterotetracyclic	 or	 hetero	
pentacyclic	 systems	 incorporating	 pyrimidine	 or	 pyrimido	
[1,2,4]triazolo	 nuclei	 in	 addition	 to	 pyranoquinoline	 moiety.	
Treatment	 of	 compound	 100	 with	 triethyl	 orthoformate	 in	
acetic	anhydride	at	reflux	gave	the	corresponding	(E)‐2‐ethoxy	
methyleneamino‐4‐(4‐chlorophenyl)‐9‐(4‐chlorostyryl)‐4H‐
pyrano[3,2‐h]quinoline‐3‐carbonitrile	 (101),	 while	 reaction	
with	hydrazine	hydrate	gave	the	cyclic	addition	product	(E)‐9‐
amino‐7‐(4‐chlorophenyl)‐2‐(4‐chlorostyryl)‐8‐imino‐8,9‐di	
hydro‐7H‐pyrimido[4',5':	 6,5]pyrano[3,2‐h]quinoline	 (102)	
(Scheme	30).	
The	 imino	 compound	 102	 proved	 to	 be	 a	 useful	
intermediate	 for	 the	 synthesis	 of	 a	 variety	 of	 2‐substituted‐
14H‐pyrimido[4',	5'	 :	6,	5]pyrano‐[3,	2‐h][1,	2,	4]triazolo[1,	5‐
c]quinoline	derivatives.	Thus,	treatment	of	compound	102	with	
ethyl	 cyanoacetate	 and	 with	 diethyl	 oxalate	 in	 refluxing	
absolute	 ethanol	 afforded	 14‐(4‐chlorophenyl)‐9‐(4‐chloro	
tyryl)‐2‐cyanomethyl‐14H‐pyrimido[4',	 5':6,	 5]pyrano[3,	 2‐h]‐
[1,2,4]triazolo[1,5‐c]quinoline	 (103a)	 and	 ethyl	 14‐(4‐chloro	
phenyl)‐9‐(4‐chlorotyryl)‐14H‐pyrimido[4',	5':6,	5]pyrano[3,	2‐
h][1,2,4]triazolo[1,5‐c]‐quinoline‐2‐carboxylate	 (103b),	 res‐
pectively.	Arylation	of	compound	102	with	benzoyl	chloride	in	
refluxing	 dry	 benzene	 proceeded	 readily	 to	 give	 the	 2‐phenyl	
derivative	103c,	respectively,	(Scheme	30).	
	
2.15.	Synthesis	from	3‐N,N‐diethylaminophenol	[53,54]		
	
Treatment	 of	 3‐N,N‐diethylaminophenol	 (104)	 with	
various	 substituted	 α‐cyanocinnamonitriles	 (2b,c)	 in	 ethanol	
and	piperidine	afforded	2‐amino	4‐(4‐chloro/bromophenyl)‐7‐
(diethylamino)‐coumarin‐3‐carbonitrile	 (105a,b).	 Treatment	
of	 105a,b	 with	 triethyl	 ortho‐formate	 in	 acetic	 anhydride	 at	
reflux	 gave	 the	 corresponding	 4‐(4‐chloro/bromophenyl)‐7‐
(diethylamino)‐2‐ethoxymethyleneamino‐4H‐chromene‐3‐
carbonitrile	 (106a,b).	 Hydrazinolysis	 of	 compound	 106a	 in	
ethanol	at	room	temperature	afforded.	
The	 aminoimino	 derivatives	 3‐amino‐5‐(4‐chloro/bromo	
phenyl)‐8‐(diethylamino)‐4‐imino‐3,4‐dihydro‐5H‐chromeno	
[2,3‐d]pyrimidine	 (107).	 Reactions	 of	 compound	 107	 with	
carboxylic	acid	derivatives	afforded	triazolopyrimidine	deriva‐
tives	 108.	 When	 compound	 107	 was	 treated	 with	 methyl	
chloroformate	 afforded	 2‐oxo‐triazolopyrimidine	 109	 via	
elimination	of	methanol.	While	treatment	compound	107	with	
ethyl	chloroformate	an	eliminated	ethanol	 to	 furnish	the	ester	
110	(Scheme	31).	
	
2.16.	Synthesis	from	5,	5‐dimethyl‐1,3‐cyclohexanedione	[55]	
	
One	 pot	 multicomponent,	 condensation	 reaction	 of	 p‐
chlorobenzaldehyde	or	3,4,5	trimethoxy	benzaldehyde,	malono	
nitrile	and	5,5‐dimethyl‐1,3‐cyclohexanedione	(111)	in	ethanol	
and	 piperidine	 afforded	 4H‐chromeno‐3‐carbonitrile	 (112).	
Treatment	 of	 compound	 112	 with	 triethyl	 orthoformate	 in	
acetic	 anhydride	 at	 reflux	 gave	 the	 corresponding	 ethoxy	
methyleneamino‐4H‐chromene‐3‐carbonitrile,	 113.	 Hydrazi‐
nolysis	 of	 compound	 113	 in	 ethanol	 at	 room	 temperature	
afforded	 the	 aminoimino	 derivatives	 114.	 Reactions	 of	
compound	 114	 with	 triethyl	 orthoformate,	 acetic	 anhydride,	
and	 p‐chlorobenzaldehyde	 in	 pyridine	 afforded	 triazolo‐
pyrimidine	derivatives	115	(Scheme	32).	
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Scheme	32
	
	
3.	Reactions	of	pyranotriazolopyrimidines	with		
	
3.1.	Phenolic	aldehydes	[25,56]	
	
Reaction	 of	 11‐methoxy‐14‐(p‐tolyl)‐14H‐naphtho[2,1‐
b]pyrano[3,2‐e][1,	2,	3]triazol[1,5‐c]pyrimidine‐2‐ethanenitrile	
(6d)	with	phenolic	aldehydes	such	as	salicylaldehyde	and	or	2‐
hydroxy‐1‐naphthaldehyde	 in	 dioxane	 refluxed	 for	 3	 h,	
afforded	 the	 corresponding	 2‐(coumarin‐3‐yl)‐11‐methoy‐14‐
(p‐tolyl)‐14H‐naphtho[2,1‐b]pyrano[3,	2‐e][1,2,4]triazolo‐[1,	5‐
c]pyrimidine	 (116)	 and	 2‐(benzo‐5:6‐coumarin‐3‐yl)‐11‐
methoy‐14‐(p‐tolyl)‐14H‐naphtho[2,	1‐b]pyrano[3,	2‐e][1,	2,	4]	
triazolo[1,5‐c]pyrimidine	(117),	respectively	(Scheme	33).	
	
	
	
3.2.	Trialkyl	phosphite	[57]	
	
Synthesis	a	series	of	α‐functionalized	 imino	ethers	26	and	
118	have	subjected	them	to	reaction	with	aqueous	solution	of	
hydrazine	 in	 methanol	 at	 0	 °C	 to	 give	 the	 naphthopyrano	
triazolopyrimidines	 119.	 The	 key	 intermediate,	 2‐chloro	
methyl‐naphthopyranotriazolopyrimidines	120,	 was	 prepared	
according	 to	 the	 literature	 procedure31,	 through	 a	 cyclization	
reaction	of	binucleophiles	119	using	chloroacetyl	chloride.	
The	 formation	 of	 naphthopyranotriazolopyrimidines	
phosphornate	121,	in	good	yield	was	carried	out	via	Michaelis‐
Arbuzov	 rearrangement	 (Arbusov	 reaction)	of	naphthopyrano	
triazolopyrimidines	 chloride	 120	 with	 trialkyl	 phosphate	
(Scheme	34).	
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4.	Applications	of	pyrano	triazolo	pyrimidines 
	
The	 chemistry	 of	 pyran	 and	 fused	 pyran	 derivatives	 has	
attracted	 many	 researchers	 due	 to	 their	 biological	 activities	
and	 their	 potential	 applications	 as	 pharmacological	 agents.	
Several	 derivatives	 of	 the	 pyran	 exhibit	 antimicrobial	 activity	
[29,53,58],	growth	stimulating	effects	[59],	antifungal	and	plant	
growth	regulation	effects	 [60],	 antitumor	activity	 [61],	 central	
nervous	system	(CNS)	activity	[62]	and	hypotensive	effect	[63].	
Moreover	pyran	derivatives	are	well	known	for	antihistaminic	
activity	 [64],	 platelet	 anti‐aggregating	 activity	 and	 local	
anaesthetic	activity	[65‐67],	antiallergenic	effect	[68],	antidep‐
ressant	effect	[69]	and	as	anti‐proliferation	agents	[70,71]	
	
4.1.	Potent	antibacterial	activities		
	
Potent	 antibacterial	 activities	 [25‐27,30,32,46,53,54]	were	
found	 naphthopyranotriazolopyrimidine	 derivatives	 (6,14,21	
and	27),	pyrazolopyranotriazolopyrimidines	 (81)	 and	 chrome	
notriazolopyrimidines	(108‐110)	(Scheme	35).	
	
 
	
Scheme	35	
	
4.2.	Antitumor	activities	
	
Chromenotriazolopyrimidines	 (41‐46)	 and	 pyrimido	
pyranotriazolo‐quinolines	(103,	122)	have	antitumor	(Scheme	
36)	[39,51,52,72].		
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Figure	2.	Biological	activity	of	pyranotriazolopyrimidines.	
	
	
4.3.	Anti‐genotoxic	activities	
	
Naphthopyranotriazolopyrimidine	 derivatives	 (27a‐g)	
have	anti‐genotoxic	activity	(Scheme	37)	[32].	
	
 
	
Scheme	37	
	
4.4.	Cytoxicity	activities	
	
Chromenotriazolopyrimidines	 (108‐110)	 have	 cytoxicity	
activities	(Scheme	38)	[54].	
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Scheme	38	
	
4.5.	Acetyl	cholinesterase	inhibition	
	
Naphthopyranotriazolopyrimidine	 derivatives	 (123)	 have	
acetyl	 cholinesterase,	 also	 known	 as	 AChE	 or	 acetylhydrolase	
inhibition	(Scheme	39)	[73].	
 
	
Scheme	39	
	
5.	Conclusions	
	
The	 present	 review	 has	 outlined	 the	 synthesis	 of	
pyranotriazolo‐pyrimidine	 derivatives	 by	 using	 key	 inter‐
mediate	 aminoimino	 pyranopyrimidines	 and	 appropriate	
carboxylic	 acid	 derivatives	 (Scheme	 40).	 Reaction	 of	 2‐aceto	
nitrile	 pyrano	 triazolo	 pyrimidines	 with	 phenolic	 aldehydes	
afforded	 coumarin	 derivatives.	 Also	 reaction	 of	 2‐chloro‐
methyl‐naphthopyranotriazolopyrimidines	with	trialkyl	phosp‐
hite	 afforded	 naphthopyranotriazolopyrimidine	 dialkyl	 phos‐
phonates.	 Pyranotriazolopyrimidine	 derivatives	 have	 been	
reported	to	furnish	interesting	biological	properties	(Figure	2).	
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